1Ameican Diabetes Associatiom,Alexamdria.The expert committee on the diagnosis and classifieation of diabetes mellitus.Diabetes Care,2003,26:3160-3167.
4[2] Pfeiffer A,Janott J,Mohlig M,et al.Circulating tumor necrosis factor-α is elevated in male but not in female patients with type 2 diabetes mellitus[J].Horm Metab Res,1997,29:111.
5[3] Pacifi R,Brown C,Puscheck E,et al.Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells[J].Proc Natl Acad Sci USA,1991,88:5134.
6[4] Lang CH,Dobrescu C,Bagby CJ.Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output[J].Endocrinology,1992,130:43.
7[5] Stephens JM,Pekala PH.Transcriptional repression of the GLU4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha[J].J Biol Chem,1991,266:21839.
8[6] Hotamisligil GS,Murray DL,Choy LN,et al.Tumor necrosis factor-alpha inhibits signaling from the insulin receptor[J].Proc Natl Acad Sci USA,1994,91:4854.
9Genuth S, Alberti KG, Bennett P, et al. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care, 2003,26:3160-3167.
10Unwin N, Shaw J, Zimmet P, et al. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med, 2002,19:708-723.
